Our Company

Our Company

Established in Europe in 2009, we are a multinational group that operates internationally and enjoys a strong presence in the major pharmaceutical markets. mAbxience is also fully committed [...]

About Us

About Us

Dr. Sigman and his biochemist wife, Silvia Gold, founded mAbxience in 2009 as the biotechnology arm of the CHEMO Group, which the couple set up in 1977. Hugo [...]

mAbBLOG

World Biosimilar Congress Europe 2016

On 14th and 15th November 2016 the 5th World Biosimilar Congress was held in Basel (Switzerland). It addressed subjects like the pre-clinical and clinical development of biosimilars, the extrapolation of indications and interchangeability, [...]

+